ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapyMillie Das, Richard H. Bruce, Robyn Bennis et al.|Lung Cancer|2012Cited by 59
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug–drug interactionMillie Das, Heather A. Wakelee, Sukhmani K. Padda et al.|Lung Cancer|2015Cited by 25